This study explores the extent to which a bilingual advantage can be observed for three tasks in an established population of fully fluent bilinguals from childhood through adulthood. Welsh-English simultaneous and early sequential bilinguals, as well as English monolinguals, aged 3 years through older adults, were tested on three sets of cognitive and executive function tasks. Bilinguals were Welsh-dominant, balanced, or English-dominant, with only Welsh, Welsh and English, or only English at home. Card sorting, Simon, and a metalinguistic judgment task (650, 557, and 354 participants, respectively) reveal little support for a bilingual advantage, either in relation to control or globally. Primarily there is no difference in performance across groups, but there is occasionally better performance by monolinguals or persons dominant in the language being tested, and in one case-in one condition and in one age group-lower performance by the monolinguals. The lack of evidence for a bilingual advantage in these simultaneous and early sequential bilinguals suggests the need for much closer scrutiny of what type of bilingual might demonstrate the reported effects, under what conditions, and why.
Transition metal
carbides (TMCs) have demonstrated outstanding
potential for utilization in a wide range of catalytic applications
because of their inherent multifunctionality and tunable composition.
However, the harsh conditions required to prepare these materials
have limited the scope of synthetic control over their physical properties.
The development of low-temperature, carburization-free routes to prepare
TMCs would unlock the versatility of this class of materials, enhance
our understanding of their physical properties, and enable their cost-effective
production at industrial scales. Here, we report an exceptionally
mild and scalable solution-phase synthesis route to phase-pure molybdenum
carbide (α-MoC1–x
) nanoparticles
(NPs) in a continuous flow millifluidic reactor. We exploit the thermolytic
decomposition of Mo(CO)6 in the presence of a surface-stabilizing
ligand and a high boiling point solvent to yield MoC1–x
NPs that are colloidally stable and resistant to
bulk oxidation in air. To demonstrate the utility of this synthetic
route to prepare catalytically active TMC NPs, we evaluated the thermochemical
CO2 hydrogenation performance of α-MoC1–x
NPs dispersed on an inert carbon support. The α-MoC1–x
/C catalyst exhibited a 2-fold increase
in both activity on a per-site basis and selectivity to C2+ products as compared to the bulk α-MoC1–x
analogue.
The translation of batch chemistries onto continuous flow platforms requires addressing the issues of consistent fluidic behaviour, channel fouling and high-throughput processing. Droplet microfluidic technologies reduce channel fouling and provide an improved level of control over heat and mass transfer to control reaction kinetics. However, in conventional geometries, the droplet size is sensitive to changes in flow rates. Here we report a three-dimensional droplet generating device that exhibits flow invariant behaviour and is robust to fluctuations in flow rate. In addition, the droplet generator is capable of producing droplet volumes spanning four orders of magnitude. We apply this device in a parallel network to synthesize platinum nanoparticles using an ionic liquid solvent, demonstrate reproducible synthesis after recycling the ionic liquid, and double the reaction yield compared with an analogous batch synthesis.
The photovoltage onset reveals the energetics of the donor states, while photovoltage size and reversibility provide information on the charge transfer dynamics of the dopants and their ability to oxidize methanol.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.